OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
	232
Impact of the COVID‐19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race	112
Molecular profiling of colorectal cancer in a genetically admixed Hispanic population	100
Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas	89
Evaluation of an artificial intelligence support system for breast cancer screening in Chinese people based on mammogram	76
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis	75
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion	72
Front‐line treatment efficacy and clinical outcomes of elderly patients with multiple myeloma in a real‐world setting: A multicenter retrospective study in China	70
Race‐specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990–2017	67
Deficiency of SR‐B1 reduced the tumor load of colitis‐induced or APC^min^/+‐induced colorectal cancer	65
Effect modification of age and hypertension on cancer and prevalence of self‐reported stroke – A cross‐sectional study	65
Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer	63
The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy	61
Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET‐amplified gastric cancer	61
Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A Nation	58
An online randomised controlled trial of prognosticating imminent death in advanced cancer patients: Clinicians give greater weight to advice from a prognostic algorithm than from another clinician wi	56
Cost‐effectiveness analysis of tumor‐infiltrating lymphocytes biomarkers guiding chemotherapy de‐escalation in early triple‐negative breast cancer	53
Characteristics of anal canal cancer in Japan	53
Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer	52
Outcomes and risk factors of SARS‐CoV‐2 omicron variant in B‐cell lymphoma patients following CD19 targeted CAR‐T therapy	52
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance data	49
Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer	48
Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer	48
Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations	48
MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements	47

SIRT2 inhibitor SirReal2 enhances anti‐tumor effects of PI3K/mTOR inhibitor VS‐5584 on acute myeloid leukemia cells	45
Health‐related quality of life and survival outcomes for patients with major depressive disorder and anxiety: A longitudinal study in pancreatic ductal adenocarcinoma	45
Family physicians' involvement in palliative cancer care	43
SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer	43
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index	43
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy	42
Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patients	42
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications	42
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)	42
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer	42
Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus	42
Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy	42
Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?	41
Evaluating the impact of COVID‐19 on cancer declarations in Quebec, Canada	41
Reasoning and causal inference regarding surgical options for patients with low‐grade gliomas using machine learning: A SEER‐based study	40